What is Locust Walk?
Locust Walk operates as a premier transaction advisory firm, bridging the gap between innovative life sciences companies and the capital markets. The firm specializes in navigating the intricate regulatory and financial landscapes inherent to the biopharmaceutical and medical technology sectors. Through a combination of deep industry expertise and strategic financial guidance, Locust Walk assists clients in executing mergers, acquisitions, and licensing agreements that define the future of global healthcare. Their market position is characterized by a high-touch, data-driven approach to corporate development, ensuring that clients achieve optimal valuation and strategic alignment during pivotal growth phases.
How much funding has Locust Walk raised?
Locust Walk has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Locust Walk
PPP
Public-Private Partnership
What's next for Locust Walk?
With the successful completion of this late-stage financing, Locust Walk is strategically positioned to scale its advisory infrastructure and deepen its penetration into emerging biotech markets. The firm is expected to prioritize the expansion of its cross-border transaction capabilities, allowing it to better serve a diverse portfolio of international clients. Furthermore, the capital will likely be deployed to bolster the firm's internal research and analytics divisions, providing clients with enhanced market intelligence and predictive modeling for complex deal structures. As the life sciences sector continues to experience rapid consolidation, Locust Walk's ability to provide sophisticated, objective guidance will remain a key differentiator in maintaining its competitive edge.
See full Locust Walk company page
